Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
G. Volpe, A. Cignetti, C. Panuzzo, Mirela Kuka +15 more

